4.3 Article

Chinese Herbal Medicine in the Treatment of Chronic Heart Failure: Three-Stage Study Protocol for a Randomized Controlled Trial

Journal

Publisher

HINDAWI LTD
DOI: 10.1155/2015/927160

Keywords

-

Funding

  1. National Basic Research Program of China [2011CB505106]
  2. National Natural Science Foundation of China [81173463, 81102730, 81302914, 81473521, 81303152]
  3. Ministry of Education [NCET-12-084, NCET-11-0607]
  4. Beijing Nova Program [xx2013032, 2011069]
  5. Innovation Team of Wei Wang in Beijing University of Chinese Medicine
  6. Project of Beijing Young Talents [YETP0821]
  7. Special Project of Chinese Administration of Traditional Chinese Medicine [537/01204, 200807007]

Ask authors/readers for more resources

Background. Chinese herbal medicine (CHM) has been used in the treatment of chronic heart failure (CHF) for a long time. Treatment based on syndrome differentiation and the main characteristic of TCM is the fundamental principle of TCM practice. In this study protocol, we have designed a trial to assess the efficacy and safety of CHM on CHF based on syndrome differentiation. Methods/Design. This is a three-stage trial of CHM in the treatment of CHF. The first stage is a literature review aiming to explore the common syndromes of CHF. The second is a multicentral, randomized, placebo-controlled trial to evaluate the efficacy and safety of CHM for the treatment of CHF. The third is a multicentral, randomized controlled clinical trial aiming to make cost-effectiveness analysis and evaluate the feasibility, compliance, and universality of CHM on CHF. Discussion. This trial will evaluate the efficacy, safety, feasibility, compliance, and universality of CHM on CHF. The expected outcome is to provide evidence-based recommendations for CHM on CHF and develop a prescription of CHM in the treatment of CHF. This trial is registered with NCT01939236 (Stage Two of the whole trial).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available